Monday, May 15, 2017
FOLLICULAR LYMPHOMA
Histopathology and biology
Chairmen: E.S. Jaffe, S.A. Pileri
E.S. Jaffe
Histology
H.G. Wendel
Biology
R. Siebert
Cytogenetics
R. Dalla Favera
Epigenetic modifiers in the pathogenesis
Front line therapy - How I approach
Chairmen: B.D. Cheson, M. Rummel
U. Ricardi
Role of radiotherapy
K.M. Ardeshna
Newly diagnosed early stage patients
G. Salles
Newly diagnosed advanced stage patients
US vs Europe: different approach on first relapse setting?
Chairman: P. Corradini
B.D. Cheson
US perspectives
A. Lopez-Guillermo
Europe perspectives
“Maintenance”: to be or not to be
Chairman: B.D. Cheson
G. Salles
PRIMA
M.E. Williams
RESORT
Lecture
J. Friedberg
Transformed follicular lymphoma
New agents
Chairmen: L.H. Sehn, A. Younes
S. de Vos
Idelalisib
M. Dreyling
Copanlisib
A. Kolstad
Betalutin
J.F. Gerecitano
Venetoclax
W. Jurczak
Rituximab Biosimilar
W. Jurczak
MOR208
P. Armand
Allotransplant
S. Schuster
CAR T cell
V. Ribrag
Tazemetostat
S.E. Assouline
Ixazomib
Tuesday, May 16, 2017
On the border…
Chairman: P.L. Zinzani
S. Treon
Waldenstrom’s disease
S. Rule
Mantle cell lymphoma
MARGINAL ZONE LYMPHOMA
Histopathology and biology
Chairmen: S.A. Pileri, M. Ponzoni
S.A. Pileri
Histology
D. Rossi
Biology and molecular genomics
M.Q. Du
Somatic mutations and mechanisms
From epidemiology... to clinical presentation
Chairmen: A.J.M. Ferreri, A. Polliack
C. Dearden
Epidemiology and environmental aspects
A. Wotherspoon
Associated autoimmunity and auto-immune disorders
C. Montalban
Prognostic models
C. Thieblemont
Clinical aspects
Treatment
Chairmen: I.S. Lossos, C. Thieblemont
J. Friedberg
Splenic MZL
C. Thieblemont
Nodal MZL
A. Stathis
Gastric MALT lymphomas
L. Arcaini
Antiviral approaches
J. Kuruvilla
Role of transplantation
